Progenics Pharmaceuticals
$4.729876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$4.72
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.08 (-1.67%) Today
$0.00 (0.00%) As of 4:01 PM EST after-hours
Why Robinhood?
You can buy or sell PGNX and other stocks, options, ETFs, and crypto commission-free!
About PGNX
Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. Read More The company was founded by Paul J. Maddon in 1986 and is headquartered in New York, NY.
Employees
79
Headquarters
New York, New York
Founded
1986
Market Cap
441.34M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.15M
High Today
$4.88
Low Today
$4.52
Open Price
$4.58
Volume
1.70M
52 Week High
$6.37
52 Week Low
$3.42
Collections
PGNX Earnings
-$0.23
-$0.15
-$0.08
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
— per share
Actual
Expected Mar 12, Pre-Market
People Also Bought
Geron
31,629
$1.15
+10.58%Viking Therapeutics
39,916
$6.00
+0.67%Verastem
17,640
$2.72
+42.41%Teva Pharmaceutical
20,942
$11.69
-4.26%Hexo
165,823
$1.12
-5.08%Aurora Cannabis
672,842
$1.38
-4.84%TherapeuticsMD
13,645
$1.69
+1.81%Chesapeake Energy
143,219
$0.2899
+11.46%Cronos Group
192,915
$5.85
-2.99%Novavax
30,484
$14.99
+27.03%Canopy Growth
177,176
$19.08
+3.47%New Age Beverages
57,179